| NCT02950441 | Aging | Dietary Supplement: Nicotinamide Riboside|Other: Placebo | University of Birmingham | Early Phase 1 | 2016-06-01 | 2016-11-04 |
| NCT00002115 | HIV Infections | Drug: Adefovir | Gilead Sciences|NIH AIDS Clinical Trials Information Service | Phase 1 | null | 2005-06-23 |
| NCT00002128 | HIV Infections | Drug: Adefovir dipivoxil | Gilead Sciences|NIH AIDS Clinical Trials Information Service | Phase 1 | null | 2005-06-23 |
| NCT00002396 | HIV Infections | Drug: Tenofovir disoproxil fumarate | Gilead Sciences|NIH AIDS Clinical Trials Information Service | Phase 1 | null | 2005-06-23 |
| NCT02752633 | Adenine Phosphoribosyltransferase Deficiency | Drug: Allopurinol|Drug: Febuxostat | Landspitali University Hospital|Mayo Clinic|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 4 | 2013-05-01 | 2016-04-22 |
| NCT00000843 | HIV Infections | Drug: Adefovir dipivoxil | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | null | 2005-06-23 |
| NCT00002180 | HIV Infections | Drug: Tenofovir | Gilead Sciences|NIH AIDS Clinical Trials Information Service | Phase 1 | null | 2005-06-23 |
| NCT02689882 | Metabolic Disturbance | Dietary Supplement: nicotinamide riboside | University of Washington|National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 | 2015-11-01 | 2016-02-18 |
| NCT00002346 | HIV Infections | Drug: Adefovir dipivoxil | Gilead Sciences|NIH AIDS Clinical Trials Information Service | Phase 1 | null | 2005-06-23 |
| NCT00002326 | HIV Infections | Drug: Adefovir|Drug: Zidovudine | Gilead Sciences|NIH AIDS Clinical Trials Information Service | Phase 1 | null | 2005-06-23 |
| NCT02942888 | Mild Cognitive Impairment|NAD | Dietary Supplement: Nicotinamide riboside|Dietary Supplement: Sugar Pill | The University of Texas Health Science Center at San Antonio|University of Texas|South Texas Veterans Health Care System | | 2016-10-01 | 2016-10-24 |
| NCT02780297 | Hyperoxaluria|Cystinuria|Dent Disease|Lowe Syndrome|Adenine Phosphoribosyltransferase Deficiency | | Mayo Clinic | | 2016-05-01 | 2016-09-19 |
| NCT01485315 | Septic Shock | Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion|Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Scandinavian Critical Care Trials Group|Copenhagen Trial Unit, Center for Clinical Intervention Research|Rigshospitalet, Denmark|University of Copenhagen | Phase 3 | 2011-11-01 | 2014-10-02 |
| NCT00561496 | HIV Infections | Drug: Tenofovir gel | CONRAD|International Partnership for Microbicides, Inc.|Gilead Sciences | Phase 1 | 2007-03-01 | 2008-05-27 |
| NCT00708721 | Cancer|Chronic Myelomonocytic Leukemia | Drug: Clofarabine | University of Utah|Genzyme, a Sanofi Company | Phase 1|Phase 2 | 2008-03-01 | 2015-01-15 |
| NCT00594373 | HIV Infections | Drug: Tenofovir gel|Drug: Tenofovir gel placebo | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | null | 2013-09-23 |
| NCT00580723 | Acne Rosacea | Other: PRK 124 | University of California, Irvine|SenetekPLC | Phase 1|Phase 2 | 2007-04-01 | 2013-12-16 |
| NCT02026388 | Primary Hyperoxaluria|Dent Disease|APRT Deficiency|Cystinuria | | Mayo Clinic | | 2013-05-01 | 2016-07-05 |
| NCT02921659 | Aging | Dietary Supplement: Niagen鈩Dietary Supplement: Placebo | University of Colorado, Boulder|ChromaDex, Inc. | Phase 1|Phase 2 | 2015-04-01 | 2016-11-29 |
| NCT01581736 | Obesity|Type 2 Diabetes Mellitus | Drug: U100 Humulin|Other: Exercise | Mayo Clinic|Arizona State University | | 2012-04-01 | 2016-05-06 |
